 Jessica Rove
Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 7 | 2024 | 721 | 2.530 |
Why?
| | Cardiac Surgical Procedures | 5 | 2024 | 499 | 2.270 |
Why?
| | Tissue and Organ Procurement | 6 | 2024 | 288 | 1.590 |
Why?
| | Extracorporeal Membrane Oxygenation | 5 | 2023 | 282 | 1.240 |
Why?
| | Thoracic Surgery | 2 | 2024 | 122 | 0.810 |
Why?
| | Educational Personnel | 1 | 2022 | 12 | 0.800 |
Why?
| | Lidocaine | 1 | 2022 | 41 | 0.790 |
Why?
| | Surgeons | 2 | 2024 | 260 | 0.790 |
Why?
| | Gelatin | 1 | 2022 | 42 | 0.790 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 112 | 0.750 |
Why?
| | Mitral Valve Insufficiency | 1 | 2022 | 67 | 0.750 |
Why?
| | General Surgery | 1 | 2022 | 152 | 0.700 |
Why?
| | Vascular Grafting | 1 | 2020 | 13 | 0.700 |
Why?
| | Phospholipases A2, Secretory | 4 | 2019 | 12 | 0.660 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2022 | 177 | 0.650 |
Why?
| | Echocardiography | 1 | 2022 | 629 | 0.640 |
Why?
| | Perfusion | 5 | 2024 | 197 | 0.630 |
Why?
| | Esophageal Neoplasms | 3 | 2017 | 295 | 0.570 |
Why?
| | Stomach Diseases | 1 | 2017 | 20 | 0.550 |
Why?
| | Organ Preservation | 4 | 2024 | 94 | 0.530 |
Why?
| | Anastomosis, Surgical | 1 | 2017 | 149 | 0.520 |
Why?
| | Esophagectomy | 1 | 2017 | 125 | 0.500 |
Why?
| | Deglutition Disorders | 1 | 2017 | 134 | 0.480 |
Why?
| | Cognition | 1 | 2023 | 1122 | 0.480 |
Why?
| | Enzyme Inhibitors | 4 | 2013 | 827 | 0.480 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 810 | 0.470 |
Why?
| | Coronary Artery Disease | 2 | 2020 | 679 | 0.470 |
Why?
| | Reoperation | 1 | 2017 | 541 | 0.460 |
Why?
| | Internship and Residency | 2 | 2020 | 1047 | 0.450 |
Why?
| | Humans | 43 | 2024 | 129266 | 0.410 |
Why?
| | Group II Phospholipases A2 | 2 | 2012 | 9 | 0.410 |
Why?
| | Lung Neoplasms | 5 | 2019 | 2342 | 0.380 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2003 | 0.380 |
Why?
| | Quality of Life | 1 | 2023 | 2687 | 0.370 |
Why?
| | Retrospective Studies | 12 | 2024 | 14461 | 0.360 |
Why?
| | Bronchiectasis | 2 | 2012 | 109 | 0.340 |
Why?
| | Postoperative Complications | 2 | 2017 | 2473 | 0.330 |
Why?
| | Pneumonectomy | 2 | 2012 | 151 | 0.330 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 3 | 2012 | 1049 | 0.330 |
Why?
| | Heart | 2 | 2023 | 637 | 0.320 |
Why?
| | Tissue Donors | 4 | 2024 | 391 | 0.310 |
Why?
| | NF-kappa B | 5 | 2012 | 665 | 0.280 |
Why?
| | Apoptosis | 4 | 2013 | 2499 | 0.280 |
Why?
| | Lung Transplantation | 2 | 2024 | 289 | 0.280 |
Why?
| | United States | 7 | 2024 | 13826 | 0.270 |
Why?
| | Osteogenesis | 2 | 2012 | 172 | 0.270 |
Why?
| | Mycobacterium Infections, Nontuberculous | 2 | 2012 | 352 | 0.270 |
Why?
| | Brain Death | 2 | 2024 | 46 | 0.260 |
Why?
| | Adult | 13 | 2024 | 35495 | 0.260 |
Why?
| | Thoracic Surgical Procedures | 2 | 2024 | 69 | 0.260 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2019 | 135 | 0.240 |
Why?
| | Aortic Valve Stenosis | 2 | 2012 | 218 | 0.240 |
Why?
| | Aortic Valve | 2 | 2012 | 347 | 0.240 |
Why?
| | Adenocarcinoma | 3 | 2013 | 898 | 0.240 |
Why?
| | Cell Proliferation | 3 | 2013 | 2375 | 0.230 |
Why?
| | Treatment Outcome | 7 | 2022 | 10202 | 0.230 |
Why?
| | Consensus | 2 | 2024 | 615 | 0.230 |
Why?
| | RNA Interference | 2 | 2012 | 450 | 0.220 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 45 | 0.210 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 29 | 0.210 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 71 | 0.210 |
Why?
| | Time Factors | 6 | 2024 | 6543 | 0.210 |
Why?
| | Physicians, Women | 1 | 2024 | 69 | 0.210 |
Why?
| | Coronary Artery Bypass | 2 | 2024 | 224 | 0.200 |
Why?
| | Biglycan | 1 | 2012 | 3 | 0.200 |
Why?
| | Travel | 1 | 2023 | 121 | 0.200 |
Why?
| | American Heart Association | 1 | 2024 | 296 | 0.200 |
Why?
| | Hernia, Inguinal | 1 | 2012 | 35 | 0.190 |
Why?
| | Herniorrhaphy | 1 | 2012 | 57 | 0.190 |
Why?
| | Echocardiography, Transesophageal | 1 | 2022 | 91 | 0.190 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 285 | 0.190 |
Why?
| | Toll-Like Receptor 2 | 1 | 2012 | 113 | 0.190 |
Why?
| | Jugular Veins | 1 | 2012 | 40 | 0.190 |
Why?
| | Hypothermia, Induced | 1 | 2022 | 76 | 0.190 |
Why?
| | Spinal Cord Ischemia | 1 | 2022 | 56 | 0.190 |
Why?
| | Technology Transfer | 1 | 2021 | 10 | 0.190 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 316 | 0.190 |
Why?
| | ras Proteins | 1 | 2012 | 144 | 0.190 |
Why?
| | Mitral Valve | 1 | 2022 | 85 | 0.190 |
Why?
| | Periodicals as Topic | 1 | 2024 | 204 | 0.190 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 40 | 0.180 |
Why?
| | Computed Tomography Angiography | 1 | 2022 | 114 | 0.180 |
Why?
| | Death | 1 | 2022 | 117 | 0.180 |
Why?
| | Thoracotomy | 2 | 2017 | 74 | 0.180 |
Why?
| | Graft Survival | 1 | 2023 | 511 | 0.180 |
Why?
| | Bronchi | 1 | 2012 | 247 | 0.180 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2011 | 43 | 0.180 |
Why?
| | Genetic Therapy | 1 | 2012 | 288 | 0.170 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2022 | 127 | 0.170 |
Why?
| | Calcinosis | 1 | 2012 | 231 | 0.170 |
Why?
| | Coronary Circulation | 1 | 2020 | 138 | 0.170 |
Why?
| | Pain, Postoperative | 1 | 2022 | 233 | 0.170 |
Why?
| | Seizures | 1 | 2023 | 401 | 0.170 |
Why?
| | Shock, Cardiogenic | 1 | 2020 | 60 | 0.170 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2022 | 231 | 0.170 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2022 | 197 | 0.160 |
Why?
| | Phosphorylation | 5 | 2013 | 1710 | 0.160 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2021 | 121 | 0.160 |
Why?
| | Blotting, Western | 5 | 2013 | 1204 | 0.160 |
Why?
| | Graft Rejection | 1 | 2023 | 598 | 0.160 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 406 | 0.160 |
Why?
| | Heart Arrest | 1 | 2022 | 320 | 0.150 |
Why?
| | Proto-Oncogene Proteins | 1 | 2012 | 635 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1365 | 0.150 |
Why?
| | Dinoprostone | 1 | 2019 | 187 | 0.150 |
Why?
| | Phylogeny | 1 | 2022 | 849 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2013 | 151 | 0.150 |
Why?
| | Health Personnel | 1 | 2024 | 648 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 2 | 2013 | 184 | 0.140 |
Why?
| | Mental Health | 1 | 2024 | 685 | 0.140 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 313 | 0.140 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2012 | 625 | 0.140 |
Why?
| | Cell Movement | 1 | 2012 | 944 | 0.140 |
Why?
| | Critical Illness | 1 | 2023 | 757 | 0.140 |
Why?
| | Gastric Emptying | 1 | 2017 | 39 | 0.140 |
Why?
| | Antineoplastic Agents | 2 | 2012 | 2054 | 0.130 |
Why?
| | Laparotomy | 1 | 2017 | 106 | 0.130 |
Why?
| | Delivery of Health Care | 1 | 2023 | 892 | 0.130 |
Why?
| | Cell Line, Tumor | 5 | 2012 | 3202 | 0.130 |
Why?
| | Anxiety | 1 | 2023 | 962 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 947 | 0.130 |
Why?
| | Hospital Mortality | 1 | 2020 | 846 | 0.130 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 422 | 0.120 |
Why?
| | Aged | 8 | 2024 | 22032 | 0.120 |
Why?
| | Hydrogels | 1 | 2022 | 629 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2012 | 757 | 0.120 |
Why?
| | Asphyxia | 1 | 2014 | 20 | 0.110 |
Why?
| | Registries | 1 | 2021 | 1895 | 0.110 |
Why?
| | Clinical Competence | 1 | 2020 | 1016 | 0.100 |
Why?
| | Middle Aged | 8 | 2024 | 31090 | 0.100 |
Why?
| | Veterans | 1 | 2024 | 1374 | 0.100 |
Why?
| | Thoracoscopy | 2 | 2012 | 52 | 0.100 |
Why?
| | Mutation | 1 | 2012 | 3710 | 0.090 |
Why?
| | Male | 11 | 2024 | 63512 | 0.090 |
Why?
| | Radiation Injuries | 1 | 2012 | 135 | 0.090 |
Why?
| | Organ Transplantation | 2 | 2024 | 228 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2012 | 2011 | 0.090 |
Why?
| | RNA, Messenger | 3 | 2012 | 2703 | 0.090 |
Why?
| | Transfection | 2 | 2012 | 915 | 0.080 |
Why?
| | Aorta, Thoracic | 2 | 2022 | 262 | 0.080 |
Why?
| | Mice | 2 | 2022 | 16915 | 0.080 |
Why?
| | Female | 9 | 2024 | 68551 | 0.080 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2012 | 63 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5384 | 0.070 |
Why?
| | Patient Selection | 2 | 2012 | 662 | 0.070 |
Why?
| | Alkaline Phosphatase | 2 | 2012 | 146 | 0.070 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 430 | 0.070 |
Why?
| | Animals | 3 | 2022 | 35309 | 0.060 |
Why?
| | Databases, Factual | 2 | 2020 | 1266 | 0.060 |
Why?
| | Aged, 80 and over | 3 | 2021 | 7055 | 0.060 |
Why?
| | Cell Survival | 2 | 2012 | 1075 | 0.060 |
Why?
| | Donor Selection | 1 | 2024 | 75 | 0.050 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 201 | 0.050 |
Why?
| | Shock | 1 | 2024 | 92 | 0.050 |
Why?
| | Cell Growth Processes | 1 | 2012 | 52 | 0.050 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 25 | 0.050 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 108 | 0.050 |
Why?
| | Surgical Mesh | 1 | 2012 | 46 | 0.050 |
Why?
| | Airway Management | 1 | 2012 | 44 | 0.050 |
Why?
| | Workplace | 1 | 2024 | 247 | 0.050 |
Why?
| | Paraplegia | 1 | 2022 | 57 | 0.050 |
Why?
| | Lipoproteins, LDL | 1 | 2012 | 127 | 0.050 |
Why?
| | Signal Transduction | 3 | 2013 | 4926 | 0.050 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 169 | 0.050 |
Why?
| | Tumor Burden | 1 | 2012 | 286 | 0.050 |
Why?
| | Blood Vessel Prosthesis | 1 | 2022 | 123 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 275 | 0.050 |
Why?
| | Occupational Health | 1 | 2024 | 192 | 0.050 |
Why?
| | Secondary Prevention | 1 | 2012 | 218 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 286 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 259 | 0.050 |
Why?
| | Organ Size | 1 | 2012 | 446 | 0.040 |
Why?
| | Mice, Nude | 1 | 2012 | 682 | 0.040 |
Why?
| | Cerebrovascular Circulation | 1 | 2022 | 227 | 0.040 |
Why?
| | Vascular Patency | 1 | 2020 | 102 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2012 | 4077 | 0.040 |
Why?
| | Antitubercular Agents | 1 | 2012 | 200 | 0.040 |
Why?
| | Anesthesia | 1 | 2012 | 134 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 263 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 483 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 398 | 0.040 |
Why?
| | Down-Regulation | 1 | 2012 | 636 | 0.040 |
Why?
| | Syndrome | 1 | 2011 | 339 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2024 | 623 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 812 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2012 | 265 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2012 | 390 | 0.040 |
Why?
| | Postoperative Care | 1 | 2011 | 241 | 0.040 |
Why?
| | Cattle | 1 | 2012 | 977 | 0.040 |
Why?
| | A549 Cells | 1 | 2019 | 59 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2012 | 1288 | 0.040 |
Why?
| | Pilot Projects | 1 | 2024 | 1584 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1290 | 0.040 |
Why?
| | Survivors | 1 | 2022 | 457 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 1001 | 0.040 |
Why?
| | Stents | 1 | 2022 | 502 | 0.040 |
Why?
| | Burnout, Professional | 1 | 2024 | 404 | 0.040 |
Why?
| | Risk | 1 | 2020 | 854 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2019 | 194 | 0.030 |
Why?
| | Biomarkers | 2 | 2012 | 3968 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2022 | 736 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1497 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2012 | 1344 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1544 | 0.030 |
Why?
| | Lung Diseases | 1 | 2012 | 739 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2012 | 3377 | 0.030 |
Why?
| | Prognosis | 1 | 2012 | 3773 | 0.030 |
Why?
| | Insulin | 1 | 2023 | 2325 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 3140 | 0.030 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 39 | 0.030 |
Why?
| | Osteopontin | 1 | 2012 | 31 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 983 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2272 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 185 | 0.020 |
Why?
| | Pravastatin | 1 | 2011 | 40 | 0.020 |
Why?
| | Heptanoic Acids | 1 | 2011 | 64 | 0.020 |
Why?
| | Simvastatin | 1 | 2011 | 60 | 0.020 |
Why?
| | Hypertension | 1 | 2020 | 1242 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 942 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5409 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2011 | 2515 | 0.020 |
Why?
| | Adolescent | 2 | 2023 | 20313 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 431 | 0.020 |
Why?
| | Pyrroles | 1 | 2011 | 202 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 839 | 0.020 |
Why?
| | Infant | 1 | 2012 | 8975 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1202 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1155 | 0.020 |
Why?
| | Suicide | 1 | 2014 | 580 | 0.020 |
Why?
| | Child, Preschool | 1 | 2012 | 10459 | 0.020 |
Why?
| | Phenotype | 1 | 2012 | 3074 | 0.010 |
Why?
| | Child | 1 | 2012 | 20785 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 12391 | 0.010 |
Why?
|
|
Rove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|